These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 300120)

  • 41. Fungal corneal ulcer and bacterial orbital cellulitis occur as complications of bacterial endophthalmitis after cataract surgery in an immunocompetent patient.
    Kim EC; Kim MS; Kang NY
    Semin Ophthalmol; 2013 Mar; 28(2):75-8. PubMed ID: 23448560
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Laboratory and clinical studies of cefmetazole in serious infection by Staphylococcus (author's transl)].
    Motohiro T; Sakata Y; Fujimoto T; Nishiyama T; Ishimoto K; Tominaga K; Yamashita F; Onoda Y; Kusayanagi T; Tsuboi M; Toubo Y; Yamamoto M; Komatsu R; Tanaka C; Baba Y
    Jpn J Antibiot; 1982 Mar; 35(3):821-34. PubMed ID: 6954289
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Clinical studies on 9, 3"-diacetylmidecamycin in respiratory tract infections in the field of pediatrics (author's transl)].
    Iwai N; Sasaki A; Taneda Y; Mizoguchi F; Nakamura H
    Jpn J Antibiot; 1982 Mar; 35(3):739-53. PubMed ID: 6285015
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Local application of neomycin in surface infections of the eye].
    Ernyei S
    Klin Monbl Augenheilkd; 1967; 150(6):887-9. PubMed ID: 5589909
    [No Abstract]   [Full Text] [Related]  

  • 45. Ophthalmic manifestations of infections caused by the USA300 clone of community-associated methicillin-resistant Staphylococcus aureus.
    Rutar T; Chambers HF; Crawford JB; Perdreau-Remington F; Zwick OM; Karr M; Diehn JJ; Cockerham KP
    Ophthalmology; 2006 Aug; 113(8):1455-62. PubMed ID: 16766029
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Clindamycin-2-phosphate: absorption, excretion metabolism, tissue levels and clinical use in surgery (author's transl)].
    Nakayama I; Iwamoto H; Iwai S; Kawabe T; Mizuashi H
    Jpn J Antibiot; 1977 Apr; 30(4):266-77. PubMed ID: 864856
    [No Abstract]   [Full Text] [Related]  

  • 47. Rabbit ocular reactivity to bacterial endotoxin contained in aqueous solution and ophthalmic viscosurgical devices.
    Buchen SY; Calogero D; Hilmantel G; Eydelman MB
    Ophthalmology; 2012 Jul; 119(7):e4-e10. PubMed ID: 22578450
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ocular distribution of difluprednate ophthalmic emulsion 0.05% in rabbits.
    Tajika T; Isowaki A; Sakaki H
    J Ocul Pharmacol Ther; 2011 Feb; 27(1):43-9. PubMed ID: 21118027
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Laboratory and clinical studies on cefoxitin in pediatric field (author's transl)].
    Iwai N; Sasaki A; Taneda Y; Osuga T; Inokuma K
    Jpn J Antibiot; 1981 Mar; 34(3):287-304. PubMed ID: 7289022
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Different concentrations of clarithromycin ophthalmic gel for rabbits corneal ulcers induced by Staphylococcus aureus].
    Wang J; Li X; Xiong L; Sun N
    Yan Ke Xue Bao; 2008 Mar; 24(1):18-22. PubMed ID: 18709951
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Intraocular penetration of DR-3355, a new quinolone derivative].
    Ooishi M; Miyao M; Okazaki O
    Jpn J Antibiot; 1991 Sep; 44(9):958-63. PubMed ID: 1960857
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment of experimental bacterial keratitis with topical trovafloxacin.
    Barequet IS; Denton P; Osterhout GJ; Tuli S; O'Brien TP
    Arch Ophthalmol; 2004 Jan; 122(1):65-9. PubMed ID: 14718297
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Laboratory and clinical studies of 6059-S in pediatric field (author's transl)].
    Nishimura T; Hiromatsu K; Takashima T; Tabuki K; Takagi M
    Jpn J Antibiot; 1981 May; 34(5):800-16. PubMed ID: 6457177
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Therapy for ocular bacterial infection.
    Baum J
    Trans Ophthalmol Soc U K (1962); 1986; 105 ( Pt 1)():69-77. PubMed ID: 3459296
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Factors affecting the intraocular penetration of antibiotics. The influence of route, inflammation, animal species and tissue pigmentation.
    Barza M
    Scand J Infect Dis Suppl; 1978; (14):151-9. PubMed ID: 100873
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Laboratory and clinical studies on cefadroxil in the field of pediatrics (author's transl)].
    Hori M; Toyonaga Y; Kurosu Y; Kumagai K
    Jpn J Antibiot; 1981 Jan; 34(1):61-76. PubMed ID: 7241807
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The successful treatment of gatifloxacin-resistant Staphylococcus aureus keratitis with Zymar (gatifloxacin 0.3%) in a NZW rabbit model.
    Romanowski EG; Mah FS; Yates KA; Kowalski RP; Gordon YJ
    Am J Ophthalmol; 2005 May; 139(5):867-77. PubMed ID: 15860293
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clindamycin as an anti-staphylococcal agent--indications and limitations.
    Hedström SA
    Scand J Infect Dis Suppl; 1984; 43():62-6. PubMed ID: 6598522
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Laboratory and clinical studies on ceftizoxime in the field of pediatrics (author's transl)].
    Toyonaga Y; Kurosu Y; Sugita M; Kawamura G; Okuyama M; Yoshino N; Hori M; Takahashi T
    Jpn J Antibiot; 1982 Jan; 35(1):9-32. PubMed ID: 6279916
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intraocular concentrations of clindamycin obtained by sequential parabulbar injections.
    Lincoff H; Kreissig I; Serag Y; Laroche D
    Klin Monbl Augenheilkd; 2000 Apr; 216(4):223-6. PubMed ID: 10820708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.